🌱 Promising Natural & Integrative Cancer Therapies (2025)
🍄 Medicinal Mushrooms
Reishi (Ganoderma lucidum): Immune-modulating, anti-tumor properties; 2025 trials studying NK cell activation in lymphoma.

Turkey Tail (Trametes versicolor): Contains PSK, boosts survival rates alongside immunotherapy in gastric cancer.

Chaga (Inonotus obliquus): High in antioxidants; lab studies suggest anti-cancer potential.


🌿 Cannabis & Cannabinoids (2025 Update)
CBD (Cannabidiol):

Non-psychoactive; reduces inflammation, limits cancer cell proliferation.

2025 trials exploring use alongside chemotherapy for glioblastoma, breast, and colon cancers.

THC (Tetrahydrocannabinol):

FDA-approved for nausea, appetite loss, and pain in cancer patients.

Early data shows anti-tumor effects in prostate, breast, and glioblastoma models.

Rick Simpson Oil (RSO):

High-THC cannabis extract with anecdotal cancer use.

2025 lab trials underway for prostate and pancreatic cancer models.

CBG (Cannabigerol):

Shows neuroprotective and possible anti-cancer synergy with CBD/THC in preclinical models.

Here's an analysis of promising natural and integrative cancer therapies, focusing on medicinal mushrooms and cannabis/cannabinoids, based on information available as of July 10, 2025.

Medicinal Mushrooms

Reishi (Ganoderma lucidum) is being studied for its immune-modulating and anti-tumor properties. Recent trials in 2025 are investigating its impact on natural killer (NK) cell activation in lymphoma patients.[1] Turkey Tail (Trametes versicolor) contains PSK, which has shown promise in boosting survival rates when used alongside immunotherapy in gastric cancer treatment.[1] Chaga (Inonotus obliquus) is rich in antioxidants, and laboratory studies suggest it may have anti-cancer potential.[1]

According to www.iAsk.Ai - Ask AI:


Cannabis & Cannabinoids

Cannabidiol (CBD) is a non-psychoactive compound known for its anti-inflammatory effects and its ability to limit cancer cell proliferation. Current trials in 2025 are exploring its use in conjunction with chemotherapy for glioblastoma, breast, and colon cancers.[1] Tetrahydrocannabinol (THC) is FDA-approved for managing nausea, appetite loss, and pain in cancer patients. Early data indicates potential anti-tumor effects in models of prostate, breast, and glioblastoma.[1] Rick Simpson Oil (RSO), a high-THC cannabis extract, is being investigated in 2025 lab trials for prostate and pancreatic cancer models, although its use is largely anecdotal.[1] Cannabigerol (CBG) shows neuroprotective properties and may have anti-cancer synergy with CBD and THC, as indicated by preclinical models.[1]

  • Promising Natural & Integrative Cancer Therapies (2025). [iAsk.Ai]

    ↩

    • Sign up for free to save this answer and access it later

    Sign up →